Husband of Sedana Medical CEO buys shares - Marketscreener.com
| SEDANA Stock | SEK 12.82 0.02 0.16% |
About 62% of Sedana Medical's investor base is looking to short. The analysis of current outlook of investing in Sedana Medical AB suggests that many traders are alarmed regarding Sedana Medical's prospects. The current market sentiment, together with Sedana Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Sedana Medical AB stock news signals to limit their universe of possible portfolio assets.
Sedana |
Husband of Sedana Medical CEO buys shares Marketscreener.com
Read at news.google.com
 |
Sedana Medical Fundamental Analysis
We analyze Sedana Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sedana Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sedana Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Sedana Medical is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sedana Medical AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sedana Medical stock to make a market-neutral strategy. Peer analysis of Sedana Medical could also be used in its relative valuation, which is a method of valuing Sedana Medical by comparing valuation metrics with similar companies.
Peers
Sedana Medical Related Equities
| ONCO | Oncopeptides | 2.48 |
| ||
| SUS | Surgical Science | 4.48 |
| ||
| SECARE | Swedencare Publ | 5.36 |
| ||
| BONEX | Bonesupport Holding | 6.05 |
|
Complementary Tools for Sedana Stock analysis
When running Sedana Medical's price analysis, check to measure Sedana Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sedana Medical is operating at the current time. Most of Sedana Medical's value examination focuses on studying past and present price action to predict the probability of Sedana Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sedana Medical's price. Additionally, you may evaluate how the addition of Sedana Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |